Gunpo-si, South Korea

Jae Min Lee

USPTO Granted Patents = 1 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Jae Min Lee**

Introduction

Jae Min Lee, an innovative inventor based in Gunpo-si, South Korea, has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific health concerns. With a focus on Janus kinase (JAK) inhibitors, Lee’s work demonstrates the potential of scientific advancements in improving therapeutic outcomes for patients.

Latest Patents

Lee holds a notable patent for a compound titled "Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine." This innovative compound functions as a Janus kinase inhibitor, potentially offering new avenues for treatment in various medical conditions where JAK pathways are implicated. His patent provides a detailed exploration of the novel substituted compound and its applications in the medical field.

Career Highlights

Throughout his career, Jae Min Lee has been associated with esteemed companies such as Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd., where he has harnessed his expertise in medicinal chemistry and drug development. His experience in these organizations has enabled him to collaborate on cutting-edge research that bridges the gap between scientific discovery and practical medicinal applications.

Collaborations

In his journey as an inventor, Lee has worked alongside notable colleagues, including Jong Min Kim and Chie Yeon Chough. These collaborations have fostered an environment of innovation, allowing for the exchange of ideas and expertise that are vital in the realm of pharmaceutical development.

Conclusion

Jae Min Lee's contributions to the field of pharmaceutical inventions, particularly with his patented Janus kinase inhibitor, exemplify the importance of innovation in advancing healthcare solutions. His work, supported by strategic collaborations and a strong professional background, continues to pave the way for new therapies that could have a lasting impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…